EUVIMEDEUVIMED entdecken
Crossref

Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort

Glenn M Stewart, Benjamin K Tong, Philip de Chazal, Joanne Flood, Yu Sun Bin, Kristina Kairaitis, John R Wheatley, Andrew S L Chan, Amanda J Piper, Brendon J Yee, Peter A Cistulli, Sydney Sleep Biobank Investigators

CHEST · 2026

DOI: 10.1016/j.chest.2025.09.136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2026. Verfasst von Glenn M Stewart und 11 weiteren Autor:innen. Beteiligte Einrichtung: Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney…. Hauptthemen laut MEDLINE: Pulse Wave Analysis, Cardiovascular Diseases, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulse oximetry-derived measures of autonomic vascular re-activity during sleep, quantified by pulse wave amplitude drop (PWAD) characteristics such as the PWAD index, have recently been proposed as a biomarker of cardiovascular disease (CVD) outcomes in patients with OSA. RESEARCH QUESTION: Are PWAD characteristics associated with Framingham 10-year CVD risk score in a sleep clinic population? STUDY DESIGN AND METHODS: This study examined PWAD characteristics in 725 individuals (38% female; median [interquartile range] age, 52 [39-63] years; BMI, 28.6 [24.9-33.2] kg/m2) who underwent diagnostic polysomnography and had sufficient clinical data to determine CVD status and calculate a Framingham 10-year CVD risk score. Individuals were categorized as either having established CVD (CVDESTABLISHED, n = 110) or a Framingham 10-year CVD risk score that was elevated (CVDELEVATED, n = 407) or low (CVDLOW, n = 208). Standard polysomnography variables and PWAD characteristics, including PWADINDEX (number of PWAD events that occurred during all sleep stages divided by total sleep time [events/h]) and PWADDURATION (average duration of PWAD events [seconds]), were compared between groups. RESULTS: The PWADINDEX was lower (P < .01) in the CVDESTABLISHED (28.5 [13.2-45.2] events/h) and CVDELEVATED (38.7 [20.8-53.0] events/h) groups than in the CVDLOW group (47.7 [35.7-62.6] events/h). The PWADDURATION was longer (P < .01) in CVDESTABLISHED (10.4 [8.2-14.5] seconds) and CVDELEVATED (8.7 [7.6-10.1] seconds) groups than in CVDLOW group (8.0 [7.2-8.8] seconds). Similar group differences were observed during rapid-eye movement and non-rapid-eye movement sleep, and in patients with and without OSA. The magnitude difference in PWADINDEX and PWADDURATION remained similar after adjusting for age, sex, BMI, BP, total sleep time, apnea-hypopnea index, and oxygen desaturation index (adjusted PWADINDEX [95% CI] was 34.2 [29.9-38.7] in CVDESTABLISHED, 39.4 [37.1-41.6] in CVDELEVATED, and 46.6 [42.5-50.7] in CVDLOW; P < .01). INTERPRETATION: These data indicate that PWAD characteristics may provide a complementary marker of CVD risk in sleep clinic populations with and without OSA. The pathophysiologic mechanisms linking nocturnal PWAD characteristics and CVD risk require further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulse Wave AnalysisCardiovascular DiseasesSleep Apnea, ObstructiveHumansFemaleMaleMiddle AgedPolysomnographyAdultRisk AssessmentOximetryHeart Disease Risk FactorsRisk FactorsSleep

Stichwörter der Autor:innen

OSApolysomnographypulse oximetrysleep disordersvascular autonomic function

Autor:innen und Institutionen

  • Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia; Department of Respiratory and Sleep Medi…
  • Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; School of Biomedical Engineering, Faculty of Engineering, University of Sydney, Camperdown, NSW, Australia.
  • Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
  • Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; Ludwig Engel Centre for Respiratory Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia; Department of Respiratory an…
  • Ludwig Engel Centre for Respiratory Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia; Department of Respiratory and Sleep Medicine, Westmead, NSW, Australia; Westmead Clinical School, Facu…
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Förderung

  • University of Sydney

Zitieren

APA

Stewart, G. M., Tong, B. K., de Chazal, P., Flood, J., Bin, Y. S., Kairaitis, K., Wheatley, J. R., Chan, A. S. L., Piper, A. J., Yee, B. J., Cistulli, P. A., & Sydney Sleep Biobank Investigators (2026). Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort. CHEST. https://doi.org/10.1016/j.chest.2025.09.136

Vancouver

Stewart GM, Tong BK, de Chazal P, Flood J, Bin YS, Kairaitis K, et al. Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort. CHEST. 2026. doi:10.1016/j.chest.2025.09.136

BibTeX
@article{Stewart2026,
  author = {Stewart, Glenn M and Tong, Benjamin K and de Chazal, Philip and Flood, Joanne and Bin, Yu Sun and Kairaitis, Kristina and Wheatley, John R and Chan, Andrew S L and Piper, Amanda J and Yee, Brendon J and Cistulli, Peter A and Sydney Sleep Biobank Investigators, Sydney Sleep Biobank Investigators},
  title = {Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort},
  journal = {CHEST},
  year = {2026},
  doi = {10.1016/j.chest.2025.09.136}
}
Kostenlos starten →